Evolus, Inc. (EOLS)
7.14
-0.55
(-7.15%)
USD |
NASDAQ |
Oct 02, 16:00
7.135
0.00 (0.00%)
After-Hours: 20:00
Evolus Market Cap : 471.34M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 471.34M |
| October 01, 2026 | 507.65M |
| September 30, 2026 | 528.11M |
| September 29, 2026 | 527.45M |
| September 28, 2026 | 525.47M |
| September 25, 2026 | 526.13M |
| September 24, 2026 | 518.87M |
| September 23, 2026 | 528.11M |
| September 22, 2026 | 544.61M |
| September 21, 2026 | 527.45M |
| September 18, 2026 | 518.87M |
| September 17, 2026 | 528.77M |
| September 16, 2026 | 527.45M |
| September 15, 2026 | 522.17M |
| September 14, 2026 | 523.49M |
| September 11, 2026 | 517.55M |
| September 10, 2026 | 522.17M |
| September 09, 2026 | 565.74M |
| September 08, 2026 | 586.20M |
| September 04, 2026 | 613.93M |
| September 03, 2026 | 597.42M |
| September 02, 2026 | 598.08M |
| September 01, 2026 | 599.40M |
| August 31, 2026 | 600.06M |
| August 28, 2026 | 586.20M |
| Date | Value |
|---|---|
| August 27, 2026 | 586.20M |
| August 26, 2026 | 579.60M |
| August 25, 2026 | 592.47M |
| August 24, 2026 | 579.60M |
| August 21, 2026 | 553.85M |
| August 20, 2026 | 551.21M |
| August 19, 2026 | 567.72M |
| August 18, 2026 | 539.99M |
| August 17, 2026 | 512.93M |
| August 14, 2026 | 538.34M |
| August 13, 2026 | 529.43M |
| August 12, 2026 | 536.03M |
| August 11, 2026 | 550.55M |
| August 10, 2026 | 499.72M |
| August 07, 2026 | 501.04M |
| August 06, 2026 | 489.16M |
| August 05, 2026 | 407.96M |
| August 04, 2026 | 404.00M |
| August 03, 2026 | 399.38M |
| July 31, 2026 | 384.50M |
| July 30, 2026 | 395.70M |
| July 29, 2026 | 397.01M |
| July 28, 2026 | 409.52M |
| July 27, 2026 | 406.89M |
| July 24, 2026 | 393.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
| Johnson & Johnson | 616.58B |
| Eli Lilly & Co. | 1.076T |
Market Cap Related Metrics
| PS Ratio | 1.473 |
| Price | 7.14 |
| Earnings Yield | -7.38% |